Celldex Therapeutics, Inc. (CLDX) scores 35 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $0.1, representing a 100% premium to fair value. Quantitative score: 53/100. Qualitative score: 20/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.